RegeneRx Biopharmaceuticals, Inc (RGN)

[surf1944]

9:00AM Regenerex Biopharam announces researchers report novel biological properties of fragments of Thymosin Beta 4 (RGN) 0.60 : Co announced that a university research team has published an article ahead of print in FASEB Journal, a high-impact scientific journal, describing novel biological properties of several Thymosin beta 4 (Tb4) peptide fragments. The researchers summarize related published studies and report on their work showing that Tb4 and these smaller peptides were able to block inflammation, reduce fibrosis, promote cell survival and block apoptosis, stimulate stem/progenitor cell differentiation, induce angiogenesis, and promote cell migration. Other activities include the induction of various genes encoded for important proteins involved in cell development (such as laminin-5, MMPs, TGF beta, zyxin, terminal deoxynucleotidyl transferase, and angiogenesis-related proteins) and activate signaling pathways that influence cell and tissue survival (such as ILK/PINCH/Akt).